Tenaya Therapeutics Inc

NASDAQ:TNYA   3:59:51 PM EDT
6.70
+1.08 (+19.22%)
Earnings Announcements

Tenaya Therapeutics Reports Fourth Quarter And Year-End 2021 Results

Published: 03/23/2022 20:51 GMT
Tenaya Therapeutics Inc (TNYA) - Tenaya Therapeutics Reports Fourth Quarter and Year-end 2021 Financial Results and Provides Business Updates.
Tenaya Therapeutics Inc - Expects Current Cash, Equivalents, Etc Will Be Sufficient to Fund Current Operating Plan at Least Into H2 2023.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.78

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.84

More details on our Analysts Page.